Eric Guerin
Director at SWKS
Board
About Eric J. Guerin
Independent director since 2022; age 53. Currently Chief Financial Officer of RB Global, Inc. (since January 2024), and designated by the Board as an Audit Committee financial expert. Tenure at Skyworks reflects independence and finance leadership across multiple industries. He serves on the Audit Committee and meets director stock ownership guidelines.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| RB Global, Inc. | Chief Financial Officer | Jan 2024 – present | Finance leadership; public company CFO |
| Veritiv Corporation | SVP–Finance; Chief Financial Officer | Jan 2023 – Mar 2023; Mar 2023 – Dec 2023 | Transitioned to CFO; operational finance |
| CDK Global Inc. | EVP & Chief Financial Officer | 2021 – 2022 | Technology solutions; capital markets exposure |
| Corning Glass Technologies (Corning Inc.) | Division VP & Sector CFO | 2016 – 2021 | Materials science, segment finance |
| Flowserve; Novartis; Johnson & Johnson Services; AstraZeneca | Financial leadership roles | Prior to 2016 | Diversified finance and operations background |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Natus Medical Incorporated | Director (public company) | Until 2022 | Past public company directorship; none currently |
| BlackBerry Limited | — | — | Not applicable to Guerin (listed for another nominee) |
| Current public company boards | — | — | None for Guerin |
Board Governance
- Independence: Board determined Guerin is independent under Nasdaq rules.
- Committee memberships: Audit Committee member; Audit Committee met 8x in FY2024.
- Committee chair roles: None; Audit chaired by David P. McGlade.
- Audit Committee financial expert: Guerin designated as financial expert and financially sophisticated.
- Board meetings and attendance: Board met 5x in FY2024; each incumbent director attended ≥75% of Board and committee meetings; all directors then in office attended the 2024 Annual Meeting.
- Executive sessions: Independent directors met in executive session 4x in FY2024.
- Director commitments policy: Executives of other public companies should not serve on more than two total public boards (including Skyworks); all 2025 nominees comply.
Fixed Compensation
| Component | FY2024 Amount | Details |
|---|---|---|
| Cash fees | $102,500 | Annual director retainer and committee member fees paid quarterly |
| Equity grant (RSUs) | $225,042 | Annual RSU grant value; 2,272 RSUs granted on May 14, 2024; vests at first anniversary |
| Unvested director RSUs outstanding (as of 9/27/24) | 2,718 | Aggregate unvested RSUs held by Guerin as of FY2024-end |
| Director stock ownership guideline | 5x base retainer | Minimum shares = $90,000×5 divided by 12-month average stock price; Guerin meets guideline |
Notes:
- Non-employee director cash schedule: base $90,000; non-chair Audit member $15,000; other committee fees per policy; Chairman and chair retainers additional if applicable.
- In change-in-control, outstanding director RSUs under the 2008 Director LTIP become fully vested.
Performance Compensation
- Skyworks does not use performance-based equity or cash metrics for non-employee director pay; director equity is time-based RSUs with annual vesting.
Other Directorships & Interlocks
| Category | Detail |
|---|---|
| Current public company boards | None |
| Prior public company boards (past 5 years) | Natus Medical Incorporated (until 2022) |
| Compensation committee interlocks | None; no insider participation or interlocks disclosed for FY2024 |
Expertise & Qualifications
- Designated Audit Committee financial expert; deep financial and operational expertise across technology, industrials, and healthcare.
- Experience spans public company CFO roles and division-level finance leadership, supporting audit oversight and capital allocation.
Equity Ownership
| Metric | Amount | Notes |
|---|---|---|
| Beneficial ownership (shares) | 5,318 | <1% of class (156,828,070 shares outstanding as of 3/1/2025) |
| Unvested director RSUs (as of 9/27/24) | 2,718 | Unvested RSUs held as director |
| Pledging/hedging | Prohibited | Company policy prohibits pledging, shorting, options, and hedging by directors and employees |
| Ownership guideline compliance | Met | All non-employee directors met guidelines as of report date (except Turcke not yet required) |
Governance Assessment
-
Strengths:
- Independent director and Audit Committee financial expert; positioned to enhance financial reporting oversight.
- Attendance and engagement: Board-wide ≥75% attendance; Audit Committee active with 8 meetings in FY2024.
- No related-party transactions above $120,000; robust related-person review policy.
- Stock ownership alignment and prohibition on pledging/hedging; clear director commitment limits.
-
Potential risk indicators (monitored):
- External executive role (CFO of RB Global) may increase time demands; however, Skyworks’ director commitments policy mitigates overboarding risk and Guerin complies.
- Industry cyclicality and audit oversight breadth: Audit Committee responsibilities include cybersecurity and AI oversight; ongoing vigilance needed.
-
Signals for investor confidence:
- Clear independence, finance expertise, and no interlocks or related-party exposure.
- Transparent director pay structure with majority equity in time-based RSUs; alignment via ownership guidelines.